GlassScriptPhysician profile
Clarene Hansen
NPI 1114985553
$11,306.51
in general payments reported to CMS, 2019-2025
45 companies · $240 in 2025
The $240 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,618 · 2022: $2,388 · 2023: $2,158 · 2024: $3,903 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,990 · Travel and Lodging: $1,311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,990.22 |
| Travel and Lodging | $1,310.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,354.91 | 2021-2025 | Minimed 780g, Minimed 770g, Inpen Smart Insulin Delivery System |
| Lilly USA, LLC | $1,372.18 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $1,229.61 | 2021-2025 | Rybelsus, Ozempic |
| Abbvie INC. | $1,125.04 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,023.72 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $618.61 | 2021-2024 | Jardiance, Tradjenta, Synjardy |
| Abbott Laboratories | $538.33 | 2021-2024 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $354.82 | 2021-2023 | |
| Tandem Diabetes Care, INC. | $320.95 | 2021-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Amgen INC. | $231.04 | 2021-2025 | Evenity, Prolia, Otezla |
| Dexcom, INC. | $217.98 | 2021-2024 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $200.82 | 2022-2024 | |
| Glaxosmithkline, LLC. | $141.51 | 2023-2025 | Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $135.95 | 2021-2025 | Verquvo, Steglatro, Belsomra |
| Pfizer INC. | $119.77 | 2022-2025 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clarene Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.